Where’s the inflation from tariffs? What stocks and earnings tell us about rising prices with June CPI on deck.
Tuesday’s consumer-price index report for June comes into sharp focus for the stock market this week.
How America’s economic policies are copying Trump’s aggressive business tactics
Trump’s budget is gambling with your savings and investments.
I’m 85 with 2 kids and $4 million. My daughter wants a larger share of my estate than my son to compensate for unequal treatment by her father.
“My daughter has severe health issues — lymphoma, which is now in remission.”
‘We are blessed’: My husband is inheriting a $1 million home. Should he put it in my name too?
“We do not live in a community-property state. We have one son who is now a young adult.”
Free trade is over in the U.S. — and Trump’s tariffs might even be working. Investors, take note.
Tariffs will become a vital source of revenue for a government that refuses to cut spending.
Trump’s letters to E.U. and Mexico threaten 30% tariffs starting Aug. 1
President Donald Trump on Saturday announced 30% tariffs on the European Union and Mexico, cementing a new high level of levies with key trading partners ahead of an Aug. 1 implementation.
Stocks and U.S. government bonds sell off in tandem Friday as trade jitters cool rally
U.S. stocks and government bonds were swept up in a selloff on Friday, as President Trump’s threats of new tariffs against a host of U.S. trade partners unnerved investors.
How Iconiq, wealth firm backed by Zuckerberg, brings rich donors together
Meta CEO Mark Zuckerberg and Square CEO Jack Dorsey. Manuel Orbegozo | Handout | Reuters A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Even as tax changes may reduce giving by […]
How AI is going to give your financial adviser new ways to manage your money
Trusted advisers will get a new life, not a pink slip.
FDA to consider drug affordability when speeding up approvals: Makary
The Food and Drug Administration will consider drug affordability when granting companies new vouchers that speed up approvals of some treatments, the agency’s Commissioner Marty Makary told CNBC on Friday. The FDA in June announced a national priority voucher plan that aims to cut drug review times to one-to-two months for companies it says are […]
